Avolta shares jump 5% after Q3 results top expectations
Avolta shares rose 5% after its third-quarter results topped expectations.
Related stories
BioMarin Signs Fabry Disease Treatment Development Deal
BioMarin signed an agreement with GC Biopharma and Hanmi to develop a treatment for Fabry disease.
M impact | EQUITY | Oct 29, 2026, 12:49 PM UTC
Alnylam Q3 Non-GAAP Net Income and Revenue Rise; 2026 Outlook Kept
M impact | EQUITY | Oct 29, 2026, 12:49 PM UTC
National Medical Care says quarterly surgeries rose 16.7%
M impact | EQUITY | Oct 29, 2026, 12:48 PM UTC
Desjardins to Acquire 100% of Bennington Shares at About 8% Discount
EQB Inc. said Desjardins will acquire all Bennington shares at a price equivalent to a discount of about 8% of lease receivables.
M impact | EQUITY | Oct 29, 2026, 12:47 PM UTC
Microsoft Prepares to Issue at Least $25 Billion in Bonds
Microsoft is moving to issue at least $25 billion in new bonds, according to investors, to fund its AI buildout. The sale would be its first since 2017.
M impact | EQUITY | Oct 29, 2026, 12:46 PM UTC
Newmark Reports Third-Quarter 2026 Financial Results
Newmark scheduled a conference call to discuss the results for 10:00 a.m. ET today.
M impact | EQUITY | Oct 29, 2026, 12:45 PM UTC